About
Stratus

Garðar Þorvarðsson, MSc in Mathematics from the University of Iceland, leads the product development team at Kvikna Medical. With nearly 30 years of experience in clinical EEG, he began his career at Taugagreining hf, where he played a key role in creating the Nervus clinical EEG system. He later joined VIASYS Healthcare, heading the design and development of the NicoletOne EEG platform. In 2008, Garðar co-founded Kvikna Medical ehf and has served as its Managing Director since inception, driving innovation in clinical EEG through pioneering cloud-based services.

ASSOCIATE PROFESSOR OF MEDICINE, DIVISION OF CARDIOVASCULAR MEDICINE, DEPARTMENT OF MEDICINE, HARVARD MEDICAL SCHOOL, BETH ISRAEL DEACONESS MEDICAL CENTER

DIRECTOR OF CARDIOLOGY GRAND ROUNDS, BETH ISRAEL DEACONESS MEDICAL CENTER

UNIVERSITY OF VIRGINIA, PH.D.

Dr. Verrier has investigated sudden cardiac death for more than three decades, having published over 300 original articles. He is inventor of 12 licensed patents for diagnosis and treatment of heart rhythm abnormalities and prediction of sudden cardiac death. During the past six years, he has focused attention on the cardiac effects of epilepsy in close collaboration with Professor Steven Schachter, a pioneer in VNS therapy and past president of AES. Their joint publications in Epilepsia and Epilepsy & Behavior have broken new ground in the study of patients with epilepsy.

PROFESSOR, DEPARTMENT CHAIR OF PSYCHOLOGY, COLORADO STATE UNIVERSITY

COLORADO STATE UNIVERSITY, PH.D.

Since 2013, Dr. Rojas has served as a faculty member in the Department of Psychology at Colorado State University. The primary theme of his work has been the identification of heritable biomarkers in autism, using non-invasive neuroimaging and electrophysiological techniques in first-degree relatives. His specialties include magnetoencephalography, electroencephalography, functional magnetic resonance imaging, autism, and schizophrenia.

ASSISTANT PROFESSOR OF NEUROLOGY, HARVARD MEDICAL SCHOOL

DIRECTOR OF CLINICAL NEUROPHYSIOLOGY AND ADULT EPILEPSY FELLOWSHIP, BETH ISRAEL DEACONESS MEDICAL CENTER

MICHAEL G. DEGROOTE SCHOOL OF MEDICINE, MD

Dr. Pang is an Assistant Professor of Neurology at Harvard Medical School and Director of the Clinical Neurophysiology and Adult Epilepsy Fellowship at Beth Israel Deaconess Medical Center. She is also Director of the comprehensive Women’s Health in Epilepsy Program, a collaborative effort across Boston medical institutions to address the special needs of women with epilepsy. Dr. Pang earned her medical degree at Michael G. DeGroote School of Medicine and specializes in the investigation and treatment of epilepsy and status epilepticus. Her clinical research includes work on T-wave alternans in patients with established or new onset epilepsy and the effects of anti-epileptic drugs and seizures on markers of sudden death in patients with epilepsy. She has published more than 20 peer-reviewed clinical papers related to epilepsy in renowned publications such as Experimental Neurology, Clinical Neurophysiology, and Seizure: European Journal of Epilepsy.

PROFESSOR, NEUROLOGY, UNIVERSITY OF CALIFORNIA SAN FRANCISCO

MEDICAL DIRECTOR, UCSF SEIZURE DISORDERS SURGERY PROGRAM

LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE NEW ORLEANS, MD

Dr. Knowlton’s research focuses on discovering advances in clinical neurophysiology and brain imaging that can affect decision-making in treatment of seizure disorders and brain tumors. The main focus of his work is to determine which advanced imaging discoveries should be moved to clinical application. He has worked specifically to improve and validate the clinical utilization of multiple modalities of brain imaging, including high-resolution magnetic resonance imaging (MRI), MR spectroscopy/spectroscopic imaging (MRS/MRSI), positron emission tomography (PET), magnetic and electrical source imaging (MSI/ESI), and ictal single photon emission computed tomography (SPECT). From the very beginning of his career, Dr. Knowlton has taken advantage of combining multiple imaging modalities to allow comparison of the relative merits for each test to determine if novel information can be discerned and measure whether purported advances improve patient care.

DIRECTOR, MID-ATLANTIC EPILEPSY AND SLEEP CENTER

CLINICAL PROFESSOR, NEUROLOGY, GEORGE WASHINGTON UNIVERSITY

CAMBRIDGE UNIVERSITY, MD

Dr. Klein’s clinical research includes novel treatments of epilepsy, dietary treatments of epilepsy in adults, prevention of epilepsy after traumatic brain injury, the effect of sex and stress hormones on epilepsy, and women with epilepsy.

He has received grants from the National Institutes of Health and the American Epilepsy Society, and investigator-initiated study grants from several pharmaceutical companies. Dr. Klein has published more than 45 peer-reviewed articles and contributed chapters to several books on epilepsy. He has been a member of the American Epilepsy Society Scientific Program Committee, Treatment Committee, and the Health Reform Task Force. Currently, he acts as a reviewer for a number of neurological, epilepsy and endocrinological journals and is chair of the AES Corporate Advisory Council. He is the Co-Founder and Co-Chair of the North American Consortium of Private Epilepsy Practices.

Omotola Hope, MD, is a board-certified neurologist who specializes in treating epilepsy and other types of seizures. Hope is a graduate of the University of Pennsylvania School of Medicine. She completed an internship in internal medicine at North Shore University Hospital in Manhasset, N.Y., and her residency in neurology at Yale New Haven Hospital in Connecticut. She also completed a fellowship in epilepsy at Yale New Haven Hospital, as well as a research fellowship through the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine. She currently treats patients at Houston Methodist Sugar Land and was previously at Memorial Hermann Hospital, where she also served as an associate professor of neurology and program director of the epilepsy fellowship at McGovern Medicine School at the University of Texas Health Science Center – Houston.

MEDICAL DIRECTOR, BIOGEN

TUFTS UNIVERSITY SCHOOL OF MEDICINE, MD

Dr. Cochrane completed his residency in neurology in the Partners Neurology Program at Massachusetts General Hospital and Brigham and Women’s Hospital (BWH). He then finished a fellowship in neuromuscular medicine and electromyography at BWH. He completed the Fellowship in Medical Ethics at Harvard Medical School, and then served as a faculty fellow at the Safra Foundation Center for Ethics at Harvard University. Since 2005, he has worked as an attending neurologist specializing in neuromuscular disease at BWH. He also worked as senior ethics consultant at BWH and served on the Partners IRB. He taught medical ethics to Harvard Medical students, residents, faculty, and nursing staff at all levels, and was the first director of neuroethics at the Center for Bioethics at Harvard Medical School. In 2018, Dr. Cochrane joined Biogen as the medical director.

DIRECTOR, UNIVERSITY OF SOUTH FLORIDA/TAMPA GENERAL HOSPITAL COMPREHENSIVE EPILEPSY PROGRAM

PROFESSOR, NEUROLOGY AT USF

Selim Benbadis, MD, is a board-certified epileptologist and clinical neurophysiologist. Benbadis graduated from medical school at the University of Nice (Nice, France), where he completed a residency in family medicine. He completed his neurology residency at the Cleveland Clinic Foundation where he stayed an additional 2 years to complete a fellowship in epilepsy, EEG, and sleep medicine. Dr. Benbadis is currently a professor of neurology at the University of South Florida and the Director of the University of South Florida /Tampa General Hospital Comprehensive Epilepsy Program. His interests are in the diagnosis and management of seizures that are difficult to control and the misdiagnosis of epilepsy. He has authored more than two hundred articles and book chapters. He also has a strong interest in medical writing and editing and serves on several editorial boards. Finally, he has a strong interest in education, serves as faculty on numerous courses each year, and has received several teaching awards.

CHIEF MEDICAL OFFICER, CENTER FOR MENTAL HEALTH

CLINICAL PROFESSOR, NEUROLOGY & PSYCHIATRY, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE

CLINICAL PROFESSOR, PSYCHIATRY, NEUROLOGY, PHYSICAL MEDICINE & REHABILITATION, BAYLOR COLLEGE OF MEDICINE

SENIOR SCIENTIST, BRAIN INJURY RESEARCH CENTER AT TIRR MEMORIAL HERMANN

UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, MD

Over the last 20 years, Dr. Arciniegas’ clinical work and patient-oriented research as a subspecialist in behavioral neurology and neuropsychiatry has focused on the phenomenology, neurobiology, and rehabilitation of the cognitive and noncognitive neuropsychiatric sequelae of traumatic brain injury (TBI), other acquired brain injuries and neurodegenerative disorders, and neurodevelopmental conditions, including schizophrenia spectrum and other psychotic disorders. He has authored more than 115 peer-reviewed journal articles, over 130 peer-reviewed abstracts, nearly three-dozen book chapters, and more than 40 additional media-related works for professional and lay audiences. He is editor of the Journal of Neuropsychiatry and Clinical Neurosciences and a member of multiple editorial and scientific review boards in the clinical neurosciences. In addition to his administrative, clinical, and academic duties, Dr. Arciniegas serves as chairman and CEO of the International Brain Injury Association, is President-elect of the International Neuropsychiatric Association, and contributes his efforts to governmental and nongovernmental organizations striving to improve the lives of persons and families affected by brain injuries

Michael Hart is the Vice President of Financial Planning & Analysis (FP&A) at Stratus, where he leads the FP&A, Revenue Cycle, and Managed Care teams. Since joining Stratus in 2016, he has played a key role in strengthening financial operations, building alignment across business functions, and supporting growth across the organization. Michael brings more than 15 years of experience in financial leadership, with expertise in financial modeling, strategic planning, and team leadership. Prior to Stratus, he held progressive roles at CIT Group, a financial services company, where he developed a reputation for data-driven decision-making and effective collaboration. He earned his MBA from California State University, Monterey Bay and holds a BBA from Texas State University. Michael is dedicated to advancing Stratus' mission of delivering best-in-class neurodiagnostic services by fostering a culture of accountability, responsiveness, and innovation.

David serves as Chief Compliance Officer for Stratus.  In this role, he oversees the Corporate Compliance Program to ensure adherence to healthcare regulations at all levels. David works within all departments to instill a strong sense of ethics and compliance within the complex and ever evolving world of healthcare regulations. David is an attorney as well and has handled a broad scope of transactional and litigation matters in private practice. He has appeared in Federal courts in Maryland, Massachusetts, Kansas, and Florida. He has extensive trial experience in Maryland state courts. David has been involved in healthcare for the past 20 years. He served as General Counsel to PDS Heart at its founding and oversaw its acquisition by Cardionet, now Biotel. David served as Chief Compliance Officer at Watermark Medical at its founding and helped pioneer the home sleep testing market. During his tenure he oversaw the company grow to become the largest provider of sleep diagnostic services in the country. He also led acquisitions of companies that provided EEG testing and DME products.

Jennifer joined Stratus in September 2019, as Vice President of Marketing. With several decades of experience in the healthcare industry, including positions at Johnson & Johnson, St. Jude Medical (now Abbott), HealthTrackRx, and Tagnos, Jennifer is a marketing leader with a proven track record for creating global marketing solutions that deliver sales results and drive strategic business initiatives. Jennifer has expertise in the identification of key market drivers, as well as the development and communication of unique selling propositions across customer segments and channels. She’s been recognized for developing collaborative, cross-functional, and cross-cultural relationships to achieve corporate objectives.

Felicia Summerville, MSc, is the Vice President of Human Resources at Stratus, where she leads enterprise-wide people strategies that drive organizational performance, workforce engagement, and scalable growth. With over 25 years of progressive HR leadership, Felicia has successfully directed teams and initiatives across diverse corporate environments, built and optimized HR infrastructures, and implemented systems and programs that improved retention, streamlined compliance, and enhanced workforce culture.  Felicia holds a Bachelor of Science in Criminal Justice/Psychology from the University of North Texas and a Master of Science in Human Resources and Business from Amberton University. She is an active member of the Texas Diversity Council, DallasHR, and the Society for Human Resource Management (SHRM). Felicia is also an alumna of North Texas Leaders & Executives Advocating Diversity (LEAD), where she continues to champion inclusive leadership and workforce equity.

Caleb oversees our clinical field teams as well as our pre and post service operations such as patient scheduling and reporting. Working his way up from being a Business Development Analyst, Caleb has been with Stratus for close to a decade and made vast improvements to ensure the fluid, efficient, and timely movement of human and capital resources across the country. He specializes in optimizing processes, building high-performing teams, and driving scalable solutions by leveraging AI technology, workflow automations, and more. At Stratus, Caleb has successfully led key initiatives that improved efficiency, supported growth, and strengthened the organization’s ability to deliver exceptional EEG services. Prior to joining Stratus in 2016, Caleb spent time in the Philadelphia Phillies MiLB system and a decade in secondary education. He holds a BBA in Economics from UL-Monroe.

Lane serves as Chief Commercial Officer for Stratus. In this role, he is charged with guiding the organization’s growth strategies and ensuring the company continues to evolve and meet the needs of customers. Lane has led growth efforts for several Fortune 500 companies, most recently as the Vice President of Business Development for Tenet Healthcare, the second largest investor owned hospital company in North America. Before joining Tenet, Lane was the Vice President of Business Development and Integration for Health Management Associates, which owned and operated over 70 hospitals across the U.S. He started his career in healthcare with Novartis Pharmaceuticals in 2002, serving in various leadership roles over his 9-year tenure. Lane is a proud graduate of the University of Alabama.

Patti, a CPA, graduated from Bradley University and began her career as an auditor in public accounting. She transitioned to the manufacturing sector and has spent the last 25 years working in healthcare. Most recently, Patti was CFO of HealthTrackRx, a clinical laboratory that provided programs for clinicians supporting responsible opioid prescribing decisions, as well as Med Fusion Clinical Laboratory, a full-service laboratory and clinical trials organization focused on cancer care. Previously, she held multiple positions at Ameripath, an anatomic pathology and esoteric laboratory. As Vice President of Finance and Billing, Hospital Division, she was responsible for the finance and billing of 28 pathology practices servicing 380 hospitals across the United States. Both Ameripath and Med Fusion were acquired by Quest Diagnostics. Patti is thrilled to be part of a market-leading healthcare provider that enhances the quality of clinical diagnoses and improves patients’ lives.

Dr. Slater serves as Chief Medical Officer for Stratus, having joined the company in 2018 after working in the field of epilepsy for more than 30 years. He founded and leads MERLN, Stratus' research and development division, which focuses on applying artificial intelligence and machine learning to clinical neurophysiology. Under his leadership, MERLN has created natural language processing databases and deep learning software to analyze EEG data for potential biomarkers of neurological conditions.

Previously, Dr. Slater served as Director of the Texas Comprehensive Epilepsy Program from 2004 to 2018, where he transformed the center from a small operation into one of the largest epilepsy surgery programs in the country, accounting for approximately 3% of all epilepsy surgeries performed nationally by 2015.

His pioneering research includes early work on artificial neural networks in clinical neurophysiology, which demonstrated these systems could distinguish disease states with higher accuracy than conventional methods. His recent research has focused on changes to brain electrical activity related to drowsiness and applications of AI in neurodiagnostics. He has authored approximately 80 scholarly publications spanning from the late 1980s through 2024, including journal articles, book chapters, and conference proceedings, with his work cited over 2,400 times in scientific literature.

In 2022, Dr. Slater was recognized as a Fellow of both the American Epilepsy Society (FAES) and the American Clinical Neurophysiology Society (FACNS), acknowledging his significant contributions to the field. He continues to provide direct patient care while advancing Stratus' mission of making neurodiagnostics more accessible through innovative technology and in-home testing solutions.

Dr. Slater earned his medical degree from the University of Pittsburgh School of Medicine and completed his neurology residency and fellowship in epilepsy and clinical neurophysiology at the University of Miami School of Medicine.

Charlie is an accomplished healthcare executive and innovator with over 30 years of leadership experience in driving growth, innovation, and operational excellence across the healthcare technology landscape. Before Stratus, Charlie served as Chief Executive Officer of DCI Health Technology Inc., a Foxconn Healthcare Technology company. Under his leadership, DCI delivered intelligent, connected digital solutions that enhanced patient safety, improved care quality, and boosted operational efficiency for health systems worldwide. Prior to DCI, Charlie was Senior Vice President of Sales and Marketing at Sotera Wireless Inc., a pioneer in wearable vital signs monitoring technology. He also co-founded and served as President of Watermark Medical, a privately held company focused on advancing sleep diagnostics and therapy to improve outcomes for patients with sleep disorders and chronic conditions. Earlier in his career, Charlie held the role of Executive Vice President of Sales at BioTel/Philips and began his journey at PSS/World Medical (now McKesson), where he rose to Vice President of Corporate Development, overseeing sales, marketing, and business development. Charlie's career is defined by a passion for transforming healthcare through innovation and a deep commitment to improving patient outcomes across the care continuum.